Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
3 pending office actions • 1 art units • 2 examiners • 0 of 3 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Remedy Robotics Inc. focuses its patent efforts within the Medical Devices & Mechanical Engineering technology area. The company currently has 3 pending office actions under review by the patent office. These actions are all concentrated within 1 distinct art unit. This concentration suggests that while the company has multiple applications in the pipeline, they are closely related in terms of technical classification and are being evaluated within the same specialized group of the patent office.
The prosecution of these matters is split between 2 distinct examiners. This requires the company to adapt its responses to 2 different individual perspectives. DAVIS, AMELIE R is the busiest examiner for the portfolio, currently managing 2 busiest examiner pending office actions. This means that a majority of the company's current pending workload is being handled by a single examiner. Practitioners should note that the outcome of these 2 busiest examiner pending office actions will significantly impact the overall success of the company's current prosecution phase.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (67%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DAVIS, AMELIE R | 2 | 65.0% | +33.4% |
| WHITROCK, ZACHARIAH KIRBY | 1 | 100.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18676954 | SYSTEMS, METHODS, AND DEVICES FOR ADVANCING AN ENDOVASCULAR INSTRUMENT | WHITROCK, ZACHARIAH KIRBY | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18352491 | IMAGE SPACE CONTROL FOR ENDOVASCULAR TOOLS | DAVIS, AMELIE R | 87d overdue |
| 18888616 | VISION-BASED POSITION AND ORIENTATION DETERMINATION FOR ENDOVASCULAR TOOLS | DAVIS, AMELIE R | — |
| Art Unit | Apps |
|---|---|
| 3798 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18888616 | VISION-BASED POSITION AND ORIENTATION DETERMINATION FOR ENDOVASCULAR TOOLS | DAVIS, AMELIE R | 3798 | §103Other | Final Rejection | — | Pending | Sep 18, 2024 |
| 18676954 | SYSTEMS, METHODS, AND DEVICES FOR ADVANCING AN ENDOVASCULAR INSTRUMENT | WHITROCK, ZACHARIAH KIRBY | — | §102§103 | Non-Final OA | — | Pending | May 29, 2024 |
| 18352491 | IMAGE SPACE CONTROL FOR ENDOVASCULAR TOOLS | DAVIS, AMELIE R | 3798 | §103Other | Non-Final OA | 87d overdue | Pending | Jul 14, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial